ACC 2020: TAILOR-PCI Trial Fails to Meet Endpoint But Still Suggests Benefits for Point-of-Care Genotyping to Guide Clopidogrel Use
Planned extended follow-up of this trial may clarify the benefits
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.